Switzerland· 67294001
Ambrisentan-Mepha
A ambrisentan product containing ambrisentanum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Ambrisentan is registered in 18 of 19 countries.
Countries holding a registration under ATC C02KX02 (ambrisentan), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 10 of them publish a price we can compare per daily dose
Ambrisentan · ATC C02KX02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ambrisentan costs, country by country.
Normalised to the WHO defined daily dose (7.5 mg), so markets compare like for like.
- Switzerland: $54.19 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Ambrisentan · price per daily dose (7.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$54.19
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- ambrisentanum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- C02KX02
- ATC class
- Ambrisentan
- Defined daily dose
- 7.5 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680672940014Blist 30 StkCHF 898.75
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
155 interactions on record for ambrisentan.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ambrisentan · interactions on record
155 records
- 5 severe
- 71 moderate
- 12 minor
- 67 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- CiclosporinL04AD01severe
- LeflunomideL04AK01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ambrisentan in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAmbrisentan 5mg tabletsAccord-UK Ltd
- CanadaAPO-AMBRISENTANAPOTEX INC
- CzechiaAMBRISENTAN ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- United StatesambrisentanSun Pharmaceutical Industries, Inc.
- SpainAMBRISENTAN ACCORD 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- NetherlandsAmbrisentan Accord 10 mg, filmomhulde tablettenAccord Healthcare B.V.
- GermanyAmbripurenPuren Pharma Gmbh & Co. Kg
- FinlandAmbrisentan AccordOrifarm Oy
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Ambrisentan Accord, Ambrisentan Aop
- Belgium · Ambrisentan Accord, Ambrisentan Sandoz
- Bulgaria · Aмбрисентан Aкорд, Амбрисентан Зентива
- Cyprus · Ambrisentan Msn, Ambrisentan Sapiens
- Czechia · Ambrisentan Accord, Ambrisentan Sandoz
- Germany · Ambripuren, Ambrisentan
- Denmark · Ambrisentan "sandoz", Ambrisentan Accord
- Estonia · Ambrisentan Inteli, Ambrisentan Norameda
- Spain · Ambrisentan Accord, Ambrisentán Aurovitas
- Finland · Ambrisentan Accord
- France · Ambrisentan Accord, Ambrisentan Arrow
- United Kingdom (Northern Ireland) · Ambrisentan Accord, Ambrisentan Axunio
- Greece · Ambicipen, Ambrisentan Accord
- Croatia · Ambrisentan Accord
- Hungary · Ambrisentan Azr
- Ireland · Ambrisentan Accord
- Iceland · Ambrisentan Viatris, Volibris
- Italy · Ambrisentan Accord, Ambrisentan Medac
- Liechtenstein · Ambrisentan Viatris, Volibris
- Lithuania · Ambrisentan Aop, Ambrisentan Inteli
- Latvia · Ambrisentan Inteli, Ambrisentan Norameda
- Netherlands · Ambrisentan Accord, Ambrisentan Aop
- Norway · Ambrisentan Accord, Ambrisentan Viatris
- Portugal · Ambrisentano Accord, Ambrisentano Generis
- Sweden · Ambrisentan Accord, Ambrisentan Bluefish
- Slovenia · Ambrisentan Accord
- Slovakia · Ambrisentan Aop
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/08671125-482f-47ef-846c-746b90c2b82b GET /v1/drugs/08671125-482f-47ef-846c-746b90c2b82b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "ambrisentanum 5 mg",
"valid_from": "2021-02-01",
"limitations": "[{\"description\":\"Behandlung der idiopathischen pulmonalen arteriellen Hypertonie (IPAH) und der PAH assoziiert mit Bindegewebserkrankungen bei Patienten der WHO-Funktionsklassen II und III zur Verbesserung der körperlichen Leistungsfähigkeit.\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2021-02-01\",\"validTo\":null}]",
"galenic_form": "Lactab 5 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2021-02-01",
"self_retention_pct": 10
}See everything about ambrisentan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.